Difference between revisions of "Journal:Mini-review of laboratory operations in biobanking: Building biobanking resources for translational research"

From LIMSWiki
Jump to navigationJump to search
(Created stub. Saving and adding more.)
 
(Saving and adding more.)
Line 32: Line 32:
'''Keywords''': disaster and risk management, biobanking and biorepositories, laboratory information management system (LIMS), biorepository operations, biospecimen research
'''Keywords''': disaster and risk management, biobanking and biorepositories, laboratory information management system (LIMS), biorepository operations, biospecimen research


==Introduction==
In the past few decades, as technology and [[Informatics (academic field)|informatics]] has expanded, scientific research has moved from [[laboratory]]-based discovery to [[translational research]], seeking to identify underlying biologic causes for disease and offer personalized treatment for patients. Large numbers of [[Sample (material)|samples]], procured from study populations that can be followed across time, have become the critical component for translational research, and the twenty-first century has shown the emergence of [[biobank]]s around the world. There are now both large population-based biobanks, and patient-based biobanks, including the Kadoorie Biobank in China<ref name="ChenChina11">{{cite journal |title=China Kadoorie Biobank of 0.5 million people: Survey methods, baseline characteristics and long-term follow-up |journal=International Journal of Epidemiology |author=Chen, Z.; Chen, J.; Collins, R. et al. |volume=40 |issue=6 |pages=1652-66 |year=2011 |doi=10.1093/ije/dyr120 |pmid=22158673 |pmc=PMC3235021}}</ref>, LifeGene in Sweden<ref name="AlmqvistLifeGene11">{{cite journal |title=LifeGene--a large prospective population-based study of global relevance |journal=International Journal of Epidemiology |author=Almqvist, C.; Adami, H.-O.; Franks, P.W. et al. |volume=26 |issue=1 |pages=67–77 |year=2011 |doi=10.1007/s10654-010-9521-x |pmid=21104112 |pmc=PMC7087900}}</ref>, CONOR and MoBa in Norway<ref name="NaessCohort08">{{cite journal |title=Cohort profile: Cohort of Norway (CONOR) |journal=International Journal of Epidemiology |author=Naess, O.; Søgaard, A.J.; Arnesen, E. et al. |volume=37 |issue=3 |pages=481–5 |year=2008 |doi=10.1093/ije/dym217 |pmid=17984119 |pmc=PMC2409050}}</ref><ref name="RønningenTheBio06">{{cite journal |title=The biobank of the Norwegian Mother and Child Cohort Study: A resource for the next 100 years |journal=European Journal of Epidemiology |author=Rønningen, K.S.; Paltiel, L.; Meltzer H.M. et al. |volume=21 |issue=8 |pages=619–24 |year=2006 |doi=10.1007/s10654-006-9041-x |pmid=17031521 |pmc=PMC1820840}}</ref>, Auria in Finland<ref name="AuriaBio">{{cite web |url=https://www.auria.fi/biopankki/en/ |title=Auria Biobank |accessdate=20 Novemember 2019}}</ref>, UK Biobank<ref name="ElliottTheUK08">{{cite journal |title=The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine |journal=International Journal of Epidemiology |author=Elliott, P.; Peakman, T.C.; UK Biobank |volume=37 |issue=2 |pages=234–44 |year=2008 |doi=10.1093/ije/dym276 |pmid=18381398}}</ref>, Estonian Biobank<ref name="LeitsaluCohort15">{{cite journal |title=Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu |journal=International Journal of Epidemiology |author=Leitsalu, L.; Haller, T.; Esko, T. et al. |volume=44 |issue=4 |pages=1137-47 |year=2015 |doi=10.1093/ije/dyt268 |pmid=24518929}}</ref>, BioBank Japan<ref name="NagaiOverview17">{{cite journal |title=Overview of the BioBank Japan Project: Study design and profile |journal=Journal of Epidemiology |author=Nagai, A.; Hirata, M.; Kamatani, Y. et al. |volume=27 |issue=3S |pages=S2–S8 |year=2017 |doi=10.1016/j.je.2016.12.005 |pmid=28189464 |pmc=PMC5350590}}</ref>, Korean Biobank<ref name="LeeNational12">{{cite journal |title=National Biobank of Korea: Quality control Programs of Collected-human Biospecimens |journal=Osong Public Health and Research Perspectives |author=Lee, J.-E.; Kim, J.-H.; Hong, E.-J. et al. |volume=3 |issue=3 |pages=185–9 |year=2012 |doi=10.1016/j.phrp.2012.07.007 |pmid=24159512 |pmc=PMC3738702}}</ref><ref name="LeePublicly16">{{cite journal |title=Publicly-funded biobanks and networks in East Asia |journal=SpringerPlus |author=Lee, S.; Jung, P.E.; Lee, Y. |volume=5 |issue=1 |at=1080 |year=2016 |doi=10.1186/s40064-016-2723-2 |pmid=27462528 |pmc=PMC4945521}}</ref>, and the Taiwan Biobank<ref name="LinNext19">{{cite journal |title=Next Chapter of the Taiwan Biobank: Sustainability and Perspectives |journal=Biopreservation and Biobanking |author=Lin, J.-C.; Chen, L.-K.; Hsiao, W.W.-W. et al. |volume=17 |issue=2 |pages=189–97 |year=2019 |doi=10.1089/bio.2018.0119 |pmid=30715914}}</ref>, as well as the Million Veteran Program<ref name="GazianoMillion16">{{cite journal |title=Million Veteran Program: A mega-biobank to study genetic influences on health and disease |journal=Journal of Clinical Epidemiology |author=Gaziano, J.M.; Concato, J.; Brophy, M. et al. |volume=70 |pages=214-23 |year=2016 |doi=10.1016/j.jclinepi.2015.09.016 |pmid=26441289}}</ref> and All of Us Biobank<ref name="AllOfTheAll19">{{cite journal |title=The "All of Us" Research Program |journal=New England Journal of Medicine |author=All of Us Research program Investigators; Denny, J.C.; Rutter, J.L. et al. |volume=381 |issue=7 |pages=668–76 |year=2019 |doi=10.1056/NEJMsr1809937 |pmid=31412182}}</ref> in the United States. Biobanks must collect, process, store, and disseminate biologic material (biospecimens) with appropriate and complete annotation in order to meet the needs of future translational researchers. A successful translational research program depends on the existence of biobanks with solid infrastructure that can provide the needed consistency in specimen collection and tracking, quality control (QC) management, and biospecimen storage, as well as disaster recovery plans and long-term financial stability. These key elements are building blocks for any biobank to be successful and for translational research to thrive. Guidelines have been established for best practices in biobanking and for biospecimen resource creation by both the [[National Cancer Institute]] (NCI)<ref name="NCIBest18">{{cite web |url=https://biospecimens.cancer.gov/bestpractices/ |title=Best Practices |author=Biorepositories & Biospecimen Research Branch (BBRB) |publisher=National Cancer Institute |date=17 December 2018 |accessdate=20 November 2019}}</ref> and the International Society for Biological and Environmental Repositories (ISBER).<ref name="CampbellThe2018">{{cite journal |title=The 2018 Revision of the ISBER Best Practices: Summary of Changes and the Editorial Team's Development Process |journal=Biopreservation and Biobanking |author=Campbell, L.D.; Astrin, J.J.; DeSouza, Y. et al. |volume=16 |issue=1 |pages=3–6 |year=2018 |doi=10.1089/bio.2018.0001 |pmid=29393664 |pmc=PMC5846567}}</ref> Here we provide an overview of important considerations for biorepository operations (Figure 1), defined herein as operational groups that support biospecimen collection and storage across multiple biobanks.


==References==
==References==

Revision as of 20:27, 31 August 2020

Full article title Mini-review of laboratory operations in biobanking: Building biobanking resources for translational research
Journal Frontiers in Public Health
Author(s) Cicek, Mine S.; Olson, Janet E.
Author affiliation(s) Mayo Clinic
Primary contact cicek dot mine at mayo dot edu
Editors Kilbourne, Amy
Year published 2020
Volume and issue 8
Article # 362
DOI 10.3389/fpubh.2020.00362
ISSN 2296-2565
Distribution license Creative Commons Attribution 4.0 International
Website https://www.frontiersin.org/articles/10.3389/fpubh.2020.00362/full
Download https://www.frontiersin.org/articles/10.3389/fpubh.2020.00362/pdf (PDF)

Abstract

Biobanks have become integral to improving population health. We are in a new era in medicine as patients, health professionals, and researchers increasingly collaborate to gain new knowledge and explore new paradigms for diagnosing and treating disease. Many large-scale biobanking efforts are underway worldwide at the institutional, national, and even international level. When linked with subject data from questionnaires and medical records, biobanks serve as valuable resources in translational research. A biobank must have high-quality biospecimens that meet researcher's needs. Biobank laboratory operations require an enormous amount of support, from lab and storage space, information technology expertise, and a laboratory information management system to logistics for sample movement, quality management systems, and appropriate facilities. A paramount metric of success for a biobank is the concept of every biospecimen coming to the repository belonging to a participant who has something to contribute to research for a healthier future. This article will discuss the importance of biorepository operations, specific to the collection and storage of participants' materials. Specific focus will be given to maintaining the quality of biospecimens, along with the various levels of support biorepositories need to fulfill their purpose and ensure the integrity of each biospecimen is maintained.

Keywords: disaster and risk management, biobanking and biorepositories, laboratory information management system (LIMS), biorepository operations, biospecimen research

Introduction

In the past few decades, as technology and informatics has expanded, scientific research has moved from laboratory-based discovery to translational research, seeking to identify underlying biologic causes for disease and offer personalized treatment for patients. Large numbers of samples, procured from study populations that can be followed across time, have become the critical component for translational research, and the twenty-first century has shown the emergence of biobanks around the world. There are now both large population-based biobanks, and patient-based biobanks, including the Kadoorie Biobank in China[1], LifeGene in Sweden[2], CONOR and MoBa in Norway[3][4], Auria in Finland[5], UK Biobank[6], Estonian Biobank[7], BioBank Japan[8], Korean Biobank[9][10], and the Taiwan Biobank[11], as well as the Million Veteran Program[12] and All of Us Biobank[13] in the United States. Biobanks must collect, process, store, and disseminate biologic material (biospecimens) with appropriate and complete annotation in order to meet the needs of future translational researchers. A successful translational research program depends on the existence of biobanks with solid infrastructure that can provide the needed consistency in specimen collection and tracking, quality control (QC) management, and biospecimen storage, as well as disaster recovery plans and long-term financial stability. These key elements are building blocks for any biobank to be successful and for translational research to thrive. Guidelines have been established for best practices in biobanking and for biospecimen resource creation by both the National Cancer Institute (NCI)[14] and the International Society for Biological and Environmental Repositories (ISBER).[15] Here we provide an overview of important considerations for biorepository operations (Figure 1), defined herein as operational groups that support biospecimen collection and storage across multiple biobanks.

References

  1. Chen, Z.; Chen, J.; Collins, R. et al. (2011). "China Kadoorie Biobank of 0.5 million people: Survey methods, baseline characteristics and long-term follow-up". International Journal of Epidemiology 40 (6): 1652-66. doi:10.1093/ije/dyr120. PMC PMC3235021. PMID 22158673. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235021. 
  2. Almqvist, C.; Adami, H.-O.; Franks, P.W. et al. (2011). "LifeGene--a large prospective population-based study of global relevance". International Journal of Epidemiology 26 (1): 67–77. doi:10.1007/s10654-010-9521-x. PMC PMC7087900. PMID 21104112. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087900. 
  3. Naess, O.; Søgaard, A.J.; Arnesen, E. et al. (2008). "Cohort profile: Cohort of Norway (CONOR)". International Journal of Epidemiology 37 (3): 481–5. doi:10.1093/ije/dym217. PMC PMC2409050. PMID 17984119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409050. 
  4. Rønningen, K.S.; Paltiel, L.; Meltzer H.M. et al. (2006). "The biobank of the Norwegian Mother and Child Cohort Study: A resource for the next 100 years". European Journal of Epidemiology 21 (8): 619–24. doi:10.1007/s10654-006-9041-x. PMC PMC1820840. PMID 17031521. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820840. 
  5. "Auria Biobank". https://www.auria.fi/biopankki/en/. Retrieved 20 Novemember 2019. 
  6. Elliott, P.; Peakman, T.C.; UK Biobank (2008). "The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine". International Journal of Epidemiology 37 (2): 234–44. doi:10.1093/ije/dym276. PMID 18381398. 
  7. Leitsalu, L.; Haller, T.; Esko, T. et al. (2015). "Cohort Profile: Estonian Biobank of the Estonian Genome Center, University of Tartu". International Journal of Epidemiology 44 (4): 1137-47. doi:10.1093/ije/dyt268. PMID 24518929. 
  8. Nagai, A.; Hirata, M.; Kamatani, Y. et al. (2017). "Overview of the BioBank Japan Project: Study design and profile". Journal of Epidemiology 27 (3S): S2–S8. doi:10.1016/j.je.2016.12.005. PMC PMC5350590. PMID 28189464. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350590. 
  9. Lee, J.-E.; Kim, J.-H.; Hong, E.-J. et al. (2012). "National Biobank of Korea: Quality control Programs of Collected-human Biospecimens". Osong Public Health and Research Perspectives 3 (3): 185–9. doi:10.1016/j.phrp.2012.07.007. PMC PMC3738702. PMID 24159512. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738702. 
  10. Lee, S.; Jung, P.E.; Lee, Y. (2016). "Publicly-funded biobanks and networks in East Asia". SpringerPlus 5 (1): 1080. doi:10.1186/s40064-016-2723-2. PMC PMC4945521. PMID 27462528. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945521. 
  11. Lin, J.-C.; Chen, L.-K.; Hsiao, W.W.-W. et al. (2019). "Next Chapter of the Taiwan Biobank: Sustainability and Perspectives". Biopreservation and Biobanking 17 (2): 189–97. doi:10.1089/bio.2018.0119. PMID 30715914. 
  12. Gaziano, J.M.; Concato, J.; Brophy, M. et al. (2016). "Million Veteran Program: A mega-biobank to study genetic influences on health and disease". Journal of Clinical Epidemiology 70: 214-23. doi:10.1016/j.jclinepi.2015.09.016. PMID 26441289. 
  13. All of Us Research program Investigators; Denny, J.C.; Rutter, J.L. et al. (2019). "The "All of Us" Research Program". New England Journal of Medicine 381 (7): 668–76. doi:10.1056/NEJMsr1809937. PMID 31412182. 
  14. Biorepositories & Biospecimen Research Branch (BBRB) (17 December 2018). "Best Practices". National Cancer Institute. https://biospecimens.cancer.gov/bestpractices/. Retrieved 20 November 2019. 
  15. Campbell, L.D.; Astrin, J.J.; DeSouza, Y. et al. (2018). "The 2018 Revision of the ISBER Best Practices: Summary of Changes and the Editorial Team's Development Process". Biopreservation and Biobanking 16 (1): 3–6. doi:10.1089/bio.2018.0001. PMC PMC5846567. PMID 29393664. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5846567. 

Notes

This presentation is faithful to the original, with only a few minor changes to presentation. A few grammar and spelling errors were also corrected. In some cases important information was missing from the references, and that information was added.